Trials / Sponsors / Provectus Biopharmaceuticals, Inc.
Provectus Biopharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver Neuroendocrine Tumors Metastatic to the Liver | Phase 1 | 2016-07-01 |
| Unknown | PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma Melanoma | Phase 1 / Phase 2 | 2015-10-01 |
| Terminated | PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma Cutaneous Melanoma | Phase 3 | 2015-04-01 |
| Unknown | A Study to Assess PV-10 Chemoablation of Cancer of the Liver Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma | Phase 1 | 2009-10-01 |
| No Longer Available | Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory, Approved Alternative Therapy | — | — |